335 related articles for article (PubMed ID: 17587252)
1. PON1 activity and genotype in patients with arterial ischemic stroke and in healthy individuals.
Schiavon R; Turazzini M; De Fanti E; Battaglia P; Targa L; Del Colle R; Fasolin A; Silvestri M; Biasioli S; Guidi G
Acta Neurol Scand; 2007 Jul; 116(1):26-30. PubMed ID: 17587252
[TBL] [Abstract][Full Text] [Related]
2. Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke.
Can Demirdöğen B; Türkanoğlu A; Bek S; Sanisoğlu Y; Demirkaya S; Vural O; Arinç E; Adali O
Clin Biochem; 2008 Jan; 41(1-2):1-9. PubMed ID: 17920578
[TBL] [Abstract][Full Text] [Related]
3. Association between PON1 5'-regulatory region polymorphisms, PON1 activity and ischemic stroke.
Kim NS; Kang BK; Cha MH; Oh SM; Ko MM; Bang OS
Clin Biochem; 2009 Jun; 42(9):857-63. PubMed ID: 19233151
[TBL] [Abstract][Full Text] [Related]
4. Human paraoxonase gene polymorphisms and coronary artery disease risk.
Mendonça MI; Dos Reis RP; Freitas AI; Sousa AC; Pereira A; Faria P; Gomes S; Silva B; Santos N; Serrão M; Ornelas I; Freitas S; Araújo JJ; Brehm A; Cardoso AA
Rev Port Cardiol; 2008 Dec; 27(12):1539-55. PubMed ID: 19280995
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between Q192R polymorphisms in paraoxonase 1 gene and young ischemic stroke].
Liu JL; Li JP; Wang XL; Yang Y
Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(13):912-6. PubMed ID: 20646512
[TBL] [Abstract][Full Text] [Related]
6. Paraoxonase (PON1) polymorphism and activity as the determinants of sensitivity to organophosphates in human subjects.
Sirivarasai J; Kaojarern S; Yoovathaworn K; Sura T
Chem Biol Interact; 2007 Jul; 168(3):184-92. PubMed ID: 17532308
[TBL] [Abstract][Full Text] [Related]
7. Association of homocysteine thiolactonase activity and PON1 polymorphisms with the severity of acute coronary syndrome.
Koubaa N; Nakbi A; Hammami S; Attia N; Mehri S; Ben Hamda K; Ben Farhat M; Miled A; Hammami M
Clin Biochem; 2009 Jun; 42(9):771-6. PubMed ID: 19269283
[TBL] [Abstract][Full Text] [Related]
8. Paraoxonase 1 gene Q192R polymorphism affects stroke and myocardial infarction risk.
Baum L; Ng HK; Woo KS; Tomlinson B; Rainer TH; Chen X; Cheung WS; Chan DK; Thomas GN; Tong CS; Wong KS
Clin Biochem; 2006 Mar; 39(3):191-5. PubMed ID: 16472799
[TBL] [Abstract][Full Text] [Related]
9. Association between serum paraoxonase (PON1) gene promoter T(-107)C polymorphism, PON1 activity and HDL levels in healthy Sicilian octogenarians.
Campo S; Sardo MA; Trimarchi G; Bonaiuto M; Fontana L; Castaldo M; Bonaiuto A; Saitta C; Bitto A; Manduca B; Riggio S; Saitta A
Exp Gerontol; 2004 Jul; 39(7):1089-94. PubMed ID: 15236768
[TBL] [Abstract][Full Text] [Related]
10. Paraoxonase gene polymorphism and serum activity in progressive IgA nephropathy.
Kovács TJ; Harris S; Vas TK; Seres I; Short CD; Wittmann IK; Paragh G; Mackness MI; Mackness B; Durrington PN; Nagy JM; Brenchley PE
J Nephrol; 2006; 19(6):732-8. PubMed ID: 17173245
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of pon1 and pon2 genes in hemodialyzed patients.
Rajković MG; Barišić K; Juretić D; Grubišić TŽ; Flegar-Meštrić Z; Rumora L
Clin Biochem; 2011 Aug; 44(12):964-8. PubMed ID: 21620813
[TBL] [Abstract][Full Text] [Related]
12. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.
Gupta N; Binukumar BK; Singh S; Sunkaria A; Kandimalla R; Bhansali A; Gill KD
Gene; 2011 Nov; 487(1):88-95. PubMed ID: 21803130
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between paraoxonase 1 55 Met/Leu, paraoxonase 2 148 Ala/Gly genetic polymorphisms and coronary artery disease].
Chi DS; Ling WH; Ma J; Xia M; Hou MJ; Wang Q; Zhu HL; Tang ZH; Yu XP
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):289-93. PubMed ID: 16767666
[TBL] [Abstract][Full Text] [Related]
14. The paraoxonase gene polymorphism in stroke patients and lipid profile.
Shin BS; Oh SY; Kim YS; Kim KW
Acta Neurol Scand; 2008 Apr; 117(4):237-43. PubMed ID: 17854416
[TBL] [Abstract][Full Text] [Related]
15. Paraoxonase 2 gene C311S polymorphism is associated with a risk of large vessel disease stroke in a Polish population.
Slowik A; Wloch D; Szermer P; Wolkow P; Malecki M; Pera J; Turaj W; Dziedzic T; Klimkowicz-Mrowiec A; Kopec G; Figlewicz DA; Szczudlik A
Cerebrovasc Dis; 2007; 23(5-6):395-400. PubMed ID: 17406108
[TBL] [Abstract][Full Text] [Related]
16. Paraoxonase polymorphisms PON1 192 and 55 and longevity in Italian centenarians and Irish nonagenarians. A pooled analysis.
Rea IM; McKeown PP; McMaster D; Young IS; Patterson C; Savage MJ; Belton C; Marchegiani F; Olivieri F; Bonafe M; Franceschi C
Exp Gerontol; 2004 Apr; 39(4):629-35. PubMed ID: 15050299
[TBL] [Abstract][Full Text] [Related]
17. Hyperhomocysteinemia, paraoxonase activity and risk of coronary artery disease.
Kerkeni M; Addad F; Chauffert M; Chuniaud L; Miled A; Trivin F; Maaroufi K
Clin Biochem; 2006 Aug; 39(8):821-5. PubMed ID: 16875684
[TBL] [Abstract][Full Text] [Related]
18. The combined effect of paraoxonase promoter and coding region polymorphisms on the risk of arterial ischemic stroke among young adults.
Voetsch B; Benke KS; Panhuysen CI; Damasceno BP; Loscalzo J
Arch Neurol; 2004 Mar; 61(3):351-6. PubMed ID: 15023811
[TBL] [Abstract][Full Text] [Related]
19. PON1 M/L55 mutation protects high-risk patients against coronary artery disease.
Oliveira SA; Mansur AP; Ribeiro CC; Ramires JA; Annichino-Bizzacchi JM
Int J Cardiol; 2004 Mar; 94(1):73-7. PubMed ID: 14996478
[TBL] [Abstract][Full Text] [Related]
20. Antioxidant effect of atorvastatin is independent of PON1 gene T(-107)C, Q192R and L55M polymorphisms in hypercholesterolaemic patients.
Sardo MA; Campo S; Bonaiuto M; Bonaiuto A; Saitta C; Trimarchi G; Castaldo M; Bitto A; Cinquegrani M; Saitta A
Curr Med Res Opin; 2005 May; 21(5):777-84. PubMed ID: 15969877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
